ArticleDiagnostics (Basel, Switzerland)2025

Hyperperfusion Improvement: A Potential Therapeutic Marker in Neuromyelitis Optica Spectrum Disorder (NMOSD).

Koichi Kimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.